Regulatory updates,
as they happen.

Nevada Legislature-posted Board of Pharmacy meeting agenda/workshop materials indicate proposed amendments to NAC 453 to add the nitazene analogs N‑pyrrolidino metonitazene and N‑pyrrolidino protonitazene to Schedule I. This signals additional controlled substance scheduling changes progressing through the state administrative process. If adopted, these substances would be regulated as Schedule I under Nevada’s Uniform Controlled Substances Act implementation (NAC 453), impacting compliance obligations for entities that may handle or encounter these substances (e.g., laboratories, healthcare/controlled-substance registrants, and enforcement).

Nevada Uniform Controlled Substances Act (NRS 453 / NAC 453)Nevada State Board of PharmacyMar 5, 2026

Deadline UpdateLive6 days ago

ECHA notes REACH restriction for PFHxA, its salts and related substances starts in April 2026

ECHA’s PFAS hot-topics page indicates that undecafluorohexanoic acid (PFHxA), its salts and related substances are subject to REACH restrictions starting in April 2026 (referenced as an already adopted restriction with a future start date). Compliance teams supplying or using PFHxA-related substances in the EU/EEA should confirm applicability, assess product/mixture impacts, and plan substitution or supply-chain controls ahead of the April 2026 restriction start date; however, the specific day in April is not provided in the extracted research text.

EU REACH Restriction (PFHxA and related substances)European Chemicals Agency (ECHA)Feb 26, 2026

Public CommentProposed6 days ago

Illinois HB4796 introduced to require Illinois DHS rescheduling within 30 days when a DEA Schedule I substance is rescheduled for mental health treatment purposes

HB4796 (104th General Assembly) is a proposed amendment affecting 720 ILCS 570/201 that would require the Illinois Department of Human Services to reschedule a substance within 30 days after publication of a Federal Register final order if the DEA reschedules a Schedule I substance for mental health treatment purposes. If enacted, this could accelerate state controlled-substance scheduling alignment in Illinois following federal rescheduling actions, with downstream impacts for healthcare providers, dispensing controls, and compliance policies around newly rescheduled therapies.

Illinois Controlled Substances Act (720 ILCS 570)Illinois General AssemblyFeb 26, 2026

Reporting RequirementLive6 days ago

Stockholm Convention Compliance Committee launches 2026–2027 information-collection questionnaires (deadline 2 March 2026)

The Stockholm Convention Compliance Committee initiated an information-collection exercise under its 2026–2027 work programme (referencing decision SC-12/22) by publishing questionnaires for Parties and for supporting entities, with responses due by 2 March 2026. Compliance teams at Parties (and relevant supporting organizations) should plan resources to complete and submit the requested information by the stated deadline, as inputs may inform compliance-related consideration under the Convention’s mechanisms.

Stockholm Convention on Persistent Organic Pollutants (POPs)Stockholm Convention Compliance Committee / BRS SecretariatFeb 26, 2026

Regulation ChangeLive6 days ago

EU Commission closes its proposal to nominate siloxanes D4, D5 and D6 under the Stockholm Convention

The European Commission’s international agreements page indicates the Commission decided to close its proposal to nominate octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5), and dodecamethylcyclohexasiloxane (D6) for listing under the Stockholm Convention. For compliance and horizon-scanning teams, this signals that this specific EU-driven nomination pathway has been halted, potentially changing expectations/timelines for any future Stockholm Convention consideration of these substances via that route.

Stockholm Convention on Persistent Organic Pollutants (POPs)European Commission, Directorate-General for EnvironmentFeb 26, 2026

Exemption UpdateLive6 days ago

Register of Specific Exemptions page details PFOA-related specific exemption entry and review milestones (e.g., review by 31 Dec 2026)

The Stockholm Convention Register of Specific Exemptions page for PFOA, its salts and PFOA-related compounds includes an exemption entry (noted in the research as for the European Union) describing a specific allowed use and setting review/assessment milestones including a review by 31 December 2026 (and periodic reviews thereafter). For compliance teams, this provides authoritative confirmation of the existence and review timing of a time-bound treaty exemption that may be relied upon by eligible Parties for the specified use while planning phase-out and future review submissions.

Stockholm Convention on Persistent Organic Pollutants (POPs)BRS Secretariat (Stockholm Convention Register of Specific Exemptions)Feb 26, 2026

View all updates →

Need full compliance tracking?

Certivo automates substance compliance across your entire product portfolio. Get alerts, track frameworks, and stay audit-ready.

Book a Demo

Regulatory updates,as they happen.

Frameworks we track

PFAS TSCA

PFAS EU REACH

TSCA

Illinois Controlled Substances Act

Stockholm POPs (2025)

ASEAN

AICIS

California Proposition 65 – 2026 Regulatory Update

NIOSH

Nevada Uniform Controlled Substances Act

EU REACH SVHC

Washington State OCIO Standard 141.10 - Securing IT Assets

EU ROHS

PRC Critical Minerals

Louisiana Uniform Controlled Dangerous Substances Law

Washington State SEC-01 Cybersecurity Program Policy

EMRT

ISCA:SB 1773 - Xylazine Classification Update

CMRT

Bellevue City Code 4.28.165 - Compost Procurement

Bellevue City Code 4.28.170 - Equal Opportunity Requirements

NIOSH Draft Skin Notation

Latest updates

Nevada Board of Pharmacy agenda/workshop materials describe proposed Schedule I additions: N‑pyrrolidino metonitazene and N‑pyrrolidino protonitazene (NAC 453)